» Articles » PMID: 30814490

RREB1-induced Upregulation of the LncRNA AGAP2-AS1 Regulates the Proliferation and Migration of Pancreatic Cancer Partly Through Suppressing ANKRD1 and ANGPTL4

Overview
Journal Cell Death Dis
Date 2019 Mar 1
PMID 30814490
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) have been reported to be involved in a variety of human diseases, including cancers. However, their mechanisms have not yet been fully elucidated. We investigated lncRNA changes that may be associated with pancreatic cancer (PC) by analyzing published microarray data, and identified AGAP2-AS1 as a relatively overexpressed lncRNA in PC tissues. qRT-PCR assays were performed to examine expression levels of AGAP2-AS1. MTT assays, colony formation assays, and EdU assays were used to determine the proliferative capacity of cells. Flow cytometry and TUNEL assays were used to study the regulation of AGAP2-AS1 in the cell cycle and apoptosis. Transwell experiments were used to study changes in cell invasion and metastasis, and a nude mouse model was established to assess the effects of AGAP2-AS1 on tumorigenesis in vivo. RNA sequencing was performed to probe AGAP2-AS1-related pathways. Subcellular fractionation and FISH assays were used to determine the distribution of AGAP2-AS1 in PC cells, and RIP and ChIP were used to determine the molecular mechanism of AGAP2-AS1-mediated regulation of potential target genes. Increased expression of AGAP2-AS1 was associated with tumor size and pathological stage progression in patients with PC. RREB1 was found to activate transcription of AGAP2-AS1 in PC cells. AGAP2-AS1 affected proliferation, apoptosis, cycle arrest, invasion, and metastasis of PC cells in vitro, and AGAP2-AS1 regulated PC proliferation in vivo. Furthermore, AGAP2-AS1 epigenetically inhibited the expression of ANKRD1 and ANGPTL4 by recruiting zeste homolog 2 (EZH2), thereby promoting PC proliferation and metastasis. In summary, our data show that RREB1-induced upregulation of AGAP2-AS1 regulates cell proliferation and migration in PC partly through suppressing ANKRD1 and ANGPTL4 by recruiting EZH2. AGAP2-AS1 represents a potential target for the diagnosis and treatment of PC in the future.

Citing Articles

Emerging roles of angiopoietin‑like 4 in human tumors (Review).

Liu R, Fu M, Chen P, Liu Y, Huang W, Sun X Int J Oncol. 2024; 66(2.

PMID: 39704206 PMC: 11753769. DOI: 10.3892/ijo.2024.5715.


Suppression of KLF5 targets RREB1 to restrain the proliferation of ovarian cancer cells through ERK/MAPK signaling pathway.

Wang S, Liu C, Li Y, Qiao J, Chen X, Bao J 3 Biotech. 2024; 15(1):4.

PMID: 39676889 PMC: 11635078. DOI: 10.1007/s13205-024-04171-8.


Identifying colorectal cancer subtypes and establishing a prognostic model using metabolic plasticity and ferroptosis genes.

Guan J, Min S, Xia Y, Guo Z, Zhou X Sci Rep. 2024; 14(1):27277.

PMID: 39516556 PMC: 11549462. DOI: 10.1038/s41598-024-78505-0.


Research progress of ankyrin repeat domain 1 protein: an updated review.

Xu X, Wang X, Li Y, Chen R, Wen H, Wang Y Cell Mol Biol Lett. 2024; 29(1):131.

PMID: 39420247 PMC: 11488291. DOI: 10.1186/s11658-024-00647-w.


Long Non-Coding RNA : A Comprehensive Overview on Its Biological Functions and Clinical Significances in Human Cancers.

Ma F, Zhang B, Wang Y, Lou C Molecules. 2024; 29(15).

PMID: 39124865 PMC: 11314102. DOI: 10.3390/molecules29153461.


References
1.
Ferre F, Colantoni A, Helmer-Citterich M . Revealing protein-lncRNA interaction. Brief Bioinform. 2015; 17(1):106-16. PMC: 4719072. DOI: 10.1093/bib/bbv031. View

2.
Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

3.
Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P . Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science. 2002; 298(5595):1039-43. DOI: 10.1126/science.1076997. View

4.
Zhang L, Sanagapalli S, Stoita A . Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018; 24(19):2047-2060. PMC: 5960811. DOI: 10.3748/wjg.v24.i19.2047. View

5.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View